Variation in comorbidity and clinical management in patients newly diagnosed with lung cancer in four Scottish centers

Journal of Thoracic Oncology

Volumn 6, Issue 3, 2011, Pages 500-509

  Grose, Derek ^a,e   Devereux, Graham ^b   Brown, Louise ^b   Jones, Richard ^a   Sharma, Dave ^c   Selby, Colin ^d   Morrison, David S ^c   Docherty, Kirsty ^a   McIntosh, David ^f   Louden, Greig ^f   Downer, Penny ^b   Nicolson, Marianne ^f   Milroy, Robert ^f  

^a BEATSON WEST OF SCOTLAND CANCER CENTRE   (United Kingdom)

^b ABERDEEN ROYAL INFIRMARY   (United Kingdom)

^c INVERCLYDE ROYAL HOSPITAL   (United Kingdom)

^d QUEEN MARGARET HOSPITAL   (United Kingdom)

^e UNIVERSITY OF GLASGOW   (United Kingdom)

^f STOBHILL HOSPITAL   (United Kingdom)

Author keywords

Epidemiology; Lung cancer; Variations in practice

Indexed keywords

ALCOHOL;

AGED; ALCOHOL CONSUMPTION; ARTICLE; CANCER CENTER; CEREBROVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; DATA BASE; DATA COLLECTION METHOD; DEMENTIA; DEMOGRAPHY; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; HEART FAILURE; HEART MUSCLE ISCHEMIA; HISTOPATHOLOGY; HUMAN; KIDNEY FUNCTION; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PERFORMANCE; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESPIRATORY FUNCTION; SMOKING; SOCIOECONOMICS; STUDY DESIGN; UNITED KINGDOM; WORLD HEALTH ORGANIZATION;

EID: 79951771457     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e318206dc10     Document Type: Article

References (37)

1. Office for National Statistics. Mortality Statistics Cause. Review of the Registrar General on Deaths by Cause, Sex and Age, in England and Wales 2005. London: Office for National Statistics, 2006.
2. Information Services Division of the NHS in Scotland. Cancer in Scotland (April 2009). Edinburgh: ISD, 2009.
3. Berrino F, De Angelis R, Milena Sant M, et al. and the EUROCARE working group: survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study. Lancet Oncol 2007;8:773-783. (Pubitemid 47321600)
4. Horner MJ, Ries LAG, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2006, Based on November 2008 SEER Data Submission, Posted to the SEER Web Site. Bethesda, MD: National Cancer Institute, 2009. Available at: .
5. Fry WA, Phillips JL, Menck HR. Ten-year survey of lung cancer treatment and survival in hospitals in the United States. Cancer 1999; 86:1867-1876. (Pubitemid 29513058)
6. Laroche C, Wells F, Coulden R, et al. Improving surgical resection rate in lung cancer. Thorax 1998;53:445-449. (Pubitemid 28308057)
7. Cartman ML, Hatfield AC, Muers MF, et al. Lung cancer: district activetreatment rates affect survival. J Epidemiol Community Health 2002;56: 424-429. (Pubitemid 34538994)
8. Damhuis RA, Schutte PR. Resection rates and postoperative mortality in 7,899 patients with lung cancer. Eur Respir J 1996;9:7-10. (Pubitemid 26037523)
9. Gregor A, Thomson CS, Brewster DH, et al. Management and survival of patients with lung cancer in Scotland diagnosed in 1995: results of a national population based study. Thorax 2001;56:212-217.
10. Janssen-Heijnen MLG, Gatta G, Forman D, et al. Variation in survival of patients with lung cancer in Europe. Eur J Cancer 1998;34:2191-2196. (Pubitemid 29036885)
11. Potosky AL, Saxman S, Wallace RB, et al. Population variations in the initial treatment of non-small cell lung cancer. J Clin Oncol 2004;22: 3261-3268. (Pubitemid 41103681)
12. Earle CC, Venditti LN, Neumann PJ, et al. Who gets chemotherapy for metastatic lung Cancer? Chest 2000;117:1239-1246. (Pubitemid 30321574)
13. Extermann M. Measuring co-morbidity in older cancer patients. Eur J Cancer 2000;36:453-471. (Pubitemid 30136223)
14. Charlson ME, Pompei P. A new method of classifying prognostic co-morbidity in longitudinal studies: development and validation. J Chron Dis 1987;40:373-383. (Pubitemid 17055592)
15. Tammemagi MC, Neslund-Dudas CMA, Simoff M, et al. Smoking and lung cancer survival: the role of co-morbidity and treatment. Chest 2004;125:27-37. (Pubitemid 38114560)
16. Janssen-Heijnen MLG, Smulders S, Lemmens VEPP, et al. Effect of co-morbidity on the treatment and prognosis of elderly patients with non-small cell lung cancer. Thorax 2004;59:602-607. (Pubitemid 38901520)
17. Colinet B, Jacot W, Bertrand D, et al. A new simplified co-morbidity score as a prognostic factor in non-small-cell lung cancer: description and comparison with the Charlson's index. Br J Cancer 2005;93:1098-1105. (Pubitemid 41670692)
18. Birim O, Pieter Kappetein A, Bogers AJCC. Charlson co-morbidity index as a predictor of long term outcome after surgery for non-smallcell lung cancer. Eur J Cardiothorac Surg 2005;28:759-762. (Pubitemid 41539333)
19. Imperatori A, Harrison RN, Leitch DN, et al. Lung cancer in Teesside (UK) and Varese (Italy): a comparison of management and survival. Thorax 2006;61:232-239.
20. Asmis TR, Ding K, Seymour L, et al. Age and comorbidity as independent prognostic factors in the treatment of non-small-cell lung cancer: a review of National Cancer Institute of Canada clinical trials group trials. J Clin Oncol 2008;26:54-59.
21. Erridge SC, Murray B, Williams L, et al. Improved survival from lung cancer in British Columbia compared to Scotland-are different treatment rates the whole story? Lung Cancer 2009;64:358-366.
22. Milroy R, Grose D, McPhelim J, et al. Impact of co-morbidity on outcome in lung cancer. Lung Cancer 2005;49:204.
23. Scottish Intercollegiate Guidelines Network (SIGN). Management of Patients with Lung Cancer, 2005. Available at: pdf/sign80.pdf.
24. WHO/ECOG Performance Status. Available at: www.ecog.org/general/ perf-stat.html.
25. Mountain CF. A new international staging system for lung cancer. Chest 1986;89(Suppl 4):225S-33S. (Pubitemid 16138265)
26. Office of the Chief Statistician, Scottish Executive. Scottish Index of Multiple Deprivation 2006: Technical Report. Available at: . scotland.gov.uk/Publications/2006/10/13142913/0.
27. National Collaborating Centre for Clinical Conditions. Management of exacerbations of COPD. Thorax 2004;59:i131-i156.
28. http://www.ccs.ca/download/position-statements/Grading%20of%20Angina.pdf Available at: 20of%20Angina.pdf.
29. The Criteria Committee of the New York Heart Association. Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels, 9th Ed. Boston, MA: Little, Brown & Co, 1994. Pp. 253-256.
30. Lyden D, Lu M, Levine S, et al. Modified National Institutes of Health Stroke Scale for use in stroke clinical trials. Stroke 2001;32:1310.
31. Morris J. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 1993;43:2412-2414. (Pubitemid 23346995)
32. Radzikowska E, Glaz P, Roszkowski K. Lung cancer in women: age, smoking, histology, performance status, stage, initial treatment and survival. Population-based study of 20 561 cases. Ann Oncol 2002;13: 1087-1093.
33. Ludbrook JJ, Truong PT, MacNeil MV. Do age and co-morbidity impact treatment allocation and outcomes in limited stage small-cell lung cancer? A community-based population. Int J Radiat Oncol Biol Phys 2003;55:1166-1168.
34. Jack R, Guilford M, Ferguson J, et al. Geographical inequalities in lung cancer management and survival in South East England: evidence of variation in access to oncology services? Br J Cancer 2003;88:1025-1031. (Pubitemid 36560769)
35. Mitchell M, Christie J, Silvestri G, et al. Racial differences pertaining to a belief about lung cancer surgery: results of a multicentre survey. Ann Intern Med 2003;139:558-563.
36. Mitchell R, Fowkes G, Blane D, et al. High rates of ischaemic heart disease in Scotland are not explained by conventional risk factors. J Epidemiol Community Health 2005;59:565-567. (Pubitemid 40904782)
37. Emslie C, Mitchell R. Are there gender differences in the geography of alcohol-related mortality in Scotland? An ecological study. BMC Public Health 2009;9:58.